Skip to content

Small loop in human prion protein shown to prevent chronic wasting disease.

Chronic wasting disease (CWD), an infectious disease caused by prions, affects North American elk and deer, but has not been observed in humans. Using a mouse model that expresses an altered form of the normal human prion protein, researchers led by the University of California have determined why the human proteins aren’t corrupted when exposed to the elk prions. The opensource study, published in the Journal of Clinical Investigation, identifies a small loop in the human prion protein that confers resistance to chronic wasting disease.

Since the loop has been found to be a key segment in prion protein aggregation, this site could be targeted for the development of new therapeutics designed to block prion conversion state the team.

Prions aren’t microorganisms like bacteria or viruses; they’re simply protein aggregates. Some prion diseases are caused by an inherited genetic mutation, while others are caused by exposure to infectious prions in food. Acquired prion diseases are triggered when a foreign, misfolded prion protein causes the body’s own natural prion proteins to misfold and aggregate.

In addition to chronic wasting disease, examples include scrapie and bovine spongiform encephalopathy, or ‘mad cow disease’, in animals and variant Creutzfeldt-Jakob disease in humans. In humans, prion diseases can cause a variety of rapidly progressive neurological symptoms, such as difficulty walking and speaking, and dementia. These diseases are 100 percent fatal and there is currently no effective treatment.

The researchers theorised that a loop in the human prion protein structure may block the elk prions from binding, as the sequences did not appear to be compatible.

To test this hypothesis the team developed a transgenic mouse that expresses a prion protein that’s identical to the human version, except for a small loop, which they swapped out for the elk prion sequence. When these mice were exposed to the elk prions, they developed chronic wasting disease.

In contrast, control mice expressing the normal human prion sequence resisted infection when exposed to same materials, just as humans seem to, even those who consume venison meat.

This finding suggests that the loop structure is crucial to prion conversion and that sequence compatibility with the host prion protein at this site is required for the transmission of certain prion diseases as well as developing a viable animal model for human prion disease research.

Source:  UC San Diego

 

Atomic space-filling and surface representations of the PrP loop highlight the side chain interactions at the zipper interface.  (A) Atomic space-filling model illustrates the view down the fibril axis. The amino acid side chains of donor cervid PrP (gray) and recipient cervid PrP (white) interdigitate in a class 3 steric zipper. (B) In contrast, the zipper interactions between the donor cervid PrP (gray) and the recipient human PrP (white), which contain yellow side chains (M166, E168, S170, N174), generate a cavity (arrow) between human S170 and cervid N170, as well as steric clash (blue rectangle) between human residue E168 and cervid residue Q168.  Human prion protein sequence elements impede cross-species chronic wasting disease transmission.   Sigurdson et al 2015.
Atomic space-filling and surface representations of the PrP loop highlight the side chain interactions at the zipper interface. (A) Atomic space-filling model illustrates the view down the fibril axis. The amino acid side chains of donor cervid PrP (gray) and recipient cervid PrP (white) interdigitate in a class 3 steric zipper. (B) In contrast, the zipper interactions between the donor cervid PrP (gray) and the recipient human PrP (white), which contain yellow side chains (M166, E168, S170, N174), generate a cavity (arrow) between human S170 and cervid N170, as well as steric clash (blue rectangle) between human residue E168 and cervid residue Q168. Human prion protein sequence elements impede cross-species chronic wasting disease transmission. Sigurdson et al 2015.

 

 

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »